Delivery Order SPE2DB20D2002-SPE2DB24FL80C
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,190.14 firm fixed-price delivery order is for the supply of 4,567,861,141 units of the medication Ondansetron HCL 8 mg Tablet. The contract has an ultimate completion date of April 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,509.99 firm fixed-price delivery order is for the supply of 4,567,926,861 units of the medication Ondansetron HCL 4 mg tablet. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.55 firm fixed-price delivery order is for the supply of 4,568,188,809 units of the prescription medication Ondansetron HCL 4 MG Tablet, with a completion date of May 9, 2025. The contract is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.63 firm-fixed-price delivery order is for 4,567,052,683 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,248.23, is a firm fixed-price delivery order for 4,563,202,968 units of the medication Ondansetron HCL 8 mg Tablet 30s. The contract has an ultimate completion date of January 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,098.88 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,658.30 Firm Fixed Price Delivery Order contract is for the supply of 4,563,165,737 units of Ondansetron HCL 8 mg tablets, with a completion date of December 22, 2023. This award is not associated with a set-aside program. It represents a task order under AmerisourceBergen's existing $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,194.07 firm fixed-price delivery order is for the supply of 4,559,929,808 units of Ondansetron HCL 8 mg tablets, with a completion date of February 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.56 firm fixed-price delivery order is for 4,566,598,430 units of the medication Ondansetron ODT 8 mg tablets, with a completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.41 firm fixed-price delivery order is for the supply of 4,566,471,926 units of Ondansetron HCL 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...